JCR Pharmaceuticals Co., Ltd.

TSE:4552 Rapporto sulle azioni

Cap. di mercato: JP¥89.8b

JCR Pharmaceuticals Gestione

Gestione criteri di controllo 2/4

JCR Pharmaceuticals Il CEO è Shin Ashida, nominato in Jun2005, ha un mandato di 19.42 anni. possiede direttamente 0.009% delle azioni della società, per un valore di ¥ 7.67M. La durata media del mandato del team dirigenziale e del consiglio di amministrazione è rispettivamente 6.4 anni e 4.8 anni.

Informazioni chiave

Shin Ashida

Amministratore delegato

n/a

Compenso totale

Percentuale dello stipendio del CEOn/a
Mandato del CEO19.4yrs
Proprietà del CEO0.009%
Durata media del management6.4yrs
Durata media del Consiglio di amministrazione4.8yrs

Aggiornamenti recenti sulla gestione

Recent updates

JCR Pharmaceuticals (TSE:4552) Is Paying Out A Dividend Of ¥10.00

Sep 06
JCR Pharmaceuticals (TSE:4552) Is Paying Out A Dividend Of ¥10.00

What JCR Pharmaceuticals Co., Ltd.'s (TSE:4552) 32% Share Price Gain Is Not Telling You

Sep 04
What JCR Pharmaceuticals Co., Ltd.'s (TSE:4552) 32% Share Price Gain Is Not Telling You

JCR Pharmaceuticals (TSE:4552) Has Affirmed Its Dividend Of ¥10.00

Aug 23
JCR Pharmaceuticals (TSE:4552) Has Affirmed Its Dividend Of ¥10.00

JCR Pharmaceuticals (TSE:4552) Is Due To Pay A Dividend Of ¥10.00

Aug 09
JCR Pharmaceuticals (TSE:4552) Is Due To Pay A Dividend Of ¥10.00

Earnings Miss: JCR Pharmaceuticals Co., Ltd. Missed EPS By 90% And Analysts Are Revising Their Forecasts

Aug 03
Earnings Miss: JCR Pharmaceuticals Co., Ltd. Missed EPS By 90% And Analysts Are Revising Their Forecasts

JCR Pharmaceuticals (TSE:4552) Will Pay A Dividend Of ¥10.00

Jul 26
JCR Pharmaceuticals (TSE:4552) Will Pay A Dividend Of ¥10.00

JCR Pharmaceuticals (TSE:4552) Is Paying Out A Dividend Of ¥10.00

Jul 12
JCR Pharmaceuticals (TSE:4552) Is Paying Out A Dividend Of ¥10.00

JCR Pharmaceuticals Co., Ltd. (TSE:4552) Shares May Have Slumped 28% But Getting In Cheap Is Still Unlikely

May 22
JCR Pharmaceuticals Co., Ltd. (TSE:4552) Shares May Have Slumped 28% But Getting In Cheap Is Still Unlikely

JCR Pharmaceuticals (TSE:4552) Is Due To Pay A Dividend Of ¥10.00

Mar 18
JCR Pharmaceuticals (TSE:4552) Is Due To Pay A Dividend Of ¥10.00

JCR Pharmaceuticals (TSE:4552) Has Affirmed Its Dividend Of ¥10.00

Feb 29
JCR Pharmaceuticals (TSE:4552) Has Affirmed Its Dividend Of ¥10.00

AMMINISTRATORE DELEGATO

Shin Ashida (81 yo)

19.4yrs

Mandato

Mr. Shin Ashida has been the Chairman of JCR Pharmaceuticals Co., Ltd. since July 1995 and its Chief Executive Officer since June 2005. Mr. Ashida has been the President and Chief Operating Officer of JCR...


Gruppo dirigente

NomePosizioneMandatoCompensazioneProprietà
Shin Ashida
Chairman19.4yrsNessun dato0.0085%
¥ 7.7m
Yoshihiro Ota
Director of Accounting Department & Corporate Strategy Department (Finance)no dataNessun datoNessun dato
Yutaka Honda
Sr. Exec. Offi. of Admin.8.4yrsNessun datoNessun dato
Hiroyuki Fukuya
Director of Legal Affairs Department - Administration Divisionno dataNessun datoNessun dato
Toru Ashida
Director4.6yrsNessun dato0.22%
¥ 193.3m
Ryutaro Makino
Director of Marketing Dept. & Group Manager of Product Planning - Marketing Dept. for Sales Div.4.1yrsNessun datoNessun dato
Katsuya Nishino
Executive Vice President14.3yrsNessun datoNessun dato
Hiroshi Yoshimoto
Senior Advisor13.5yrsNessun datoNessun dato
Takayo Egawa
Senior Executive Officer & Director of International Affairsno dataNessun datoNessun dato
Toshihiro Ishikiriyama
Senior Managing Executive Officer & Executive Director of Business Development Divisionless than a yearNessun dato0.0066%
¥ 5.9m
Hiroyuki Sonoda
Senior Managing Executive Officer of Research6.4yrsNessun dato0.0019%
¥ 1.7m
Junichi Ando
Managing Executive Officer of Production & Executive Director of Production Division3.4yrsNessun datoNessun dato

6.4yrs

Durata media

70yo

Età media

Gestione esperta: Il team dirigenziale di 4552 è esperto e expertise (durata media dell'incarico 6.4 anni).


Membri del Consiglio di amministrazione

NomePosizioneMandatoCompensazioneProprietà
Shin Ashida
Chairman19.4yrsNessun dato0.0085%
¥ 7.7m
Toru Ashida
Directorno dataNessun dato0.22%
¥ 193.3m
Hiroyuki Sonoda
Senior Managing Executive Officer of Research4.8yrsNessun dato0.0019%
¥ 1.7m
Yoshio Hiyama
Director3.4yrsNessun dato0.0021%
¥ 1.9m
Andrea Spezzi
Director & Managing Executive Officer of Development Divisionless than a yearNessun datoNessun dato
Marc Dunoyer
Independent Outside Director1.4yrsNessun datoNessun dato
Kazuhiko Yamada
Outside Audit & Supervisory Board Member18.4yrsNessun dato0.010%
¥ 9.4m
Philippe Fauchet
Independent Outside Director2.4yrsNessun datoNessun dato
Toshihide Yoda
Independent Outside Director6.4yrsNessun datoNessun dato
Yutaka Atomi
Independent Outside Director2.4yrsNessun datoNessun dato
Takashi Suetsuna
Independent Outside Director7.4yrsNessun datoNessun dato
Yuko Hayashi
Independent Outside Director6.4yrsNessun datoNessun dato

4.8yrs

Durata media

65.5yo

Età media

Consiglio di amministrazione esperto: I membri del consiglio di amministrazione di 4552 sono considerati esperti (durata media dell'incarico 4.8 anni).